Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

NCT01485991

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Bakersfield, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
  • Washington D.C., District of Columbia, United States
View all 137 locations
View Trial Details
Completed

Study of a New MVA Vaccine for Hepatitis C Virus

NCT01296451

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom
  • John Radcliffe Hospital, Headley Way Headington, Oxford, United Kingdom
  • Wycombe Hospital, High Wycombe, Buckinghamshire High Wycombe, United Kingdom
View Trial Details
Completed

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

NCT01970904

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Cologne, Germany
  • Novartis Investigative Site Düsseldorf, Germany
View all 25 locations
View Trial Details
Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

NCT02114177

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • Dothan, Alabama, United States
  • Bakersfield, California, United States
  • Chula Vista, California, United States
  • Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study

NCT01323244

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Bakersfield, California, United States
  • Los Angeles, California, United States
  • San Diego, California, United States
  • Englewood, Colorado, United States
View all 72 locations
View Trial Details
Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

NCT02114151

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • Dothan, Alabama, United States
  • Bakersfield, California, United States
  • Chula Vista, California, United States
  • Los Angeles, California, United States
View all 34 locations
View Trial Details

Related conditions